Robert Mo

Robert Mo is a highly experienced pharmaceutical professional with a Doctor of Philosophy (Ph.D.) in Pharmaceutical Sciences from the University of Southern California. Currently serving as Senior Director of CMC Development at PharmaBlock Group since March 2023, Robert has previously held key positions at Akebia Therapeutics, where responsibilities included leading drug product development and manufacturing teams and overseeing the registration objectives for Vafseo™. Robert's extensive background also includes significant roles at Pfizer, where as Senior Scientist, development of oral and parenteral formulations was a focus, and at Allergan, where advancement of dermal drug formulations was achieved. Educational qualifications also feature a Bachelor of Science (BS) in Biomedical Engineering from Columbia Engineering and studies in finance at Harvard Extension School.